|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Real estate investment properties, net (including $55,941 related to consolidated variable interest entities) | ||||||||||||||||||
| Assets held for sale, net | ||||||||||||||||||
| Investment in unconsolidated entity | ||||||||||||||||||
| Investments in and advances to unconsolidated entities | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Deferred rent and lease incentives | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Intangibles, net | ||||||||||||||||||
| Mortgages and other notes receivable, net | ||||||||||||||||||
| Accounts and other receivables, net | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| Mortgages and other notes payable (including $18,628 related to non-recourse debt of consolidated variable interest entities) | ||||||||||||||||||
| Senior notes, net of discount | ||||||||||||||||||
| Liabilities related to assets held for sale | ||||||||||||||||||
| Line of credit | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||
| Income tax liabilities | ||||||||||||||||||
| Due to affiliates | ||||||||||||||||||
| Total Liabilities | ||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||
| Preferred stock, $.01 par value per share 200 million shares authorized and unissued | ||||||||||||||||||
| Excess shares, $.01 par value per share 120 million shares authorized and unissued | ||||||||||||||||||
| Common stock, $.01 par value per share | ||||||||||||||||||
| One billion shares authorized; 349,084 shares issued and 325,183 shares outstanding | ||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated distributions | ||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||
| Total Liabilities and Stockholders’ Equity |
Loading...
